• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泰国北部传统骨肉瘤的生存率及预后因素:清迈大学医院的系列研究

Survival rate and prognostic factors of conventional osteosarcoma in Northern Thailand: A series from Chiang Mai University Hospital.

作者信息

Pruksakorn Dumnoensun, Phanphaisarn Areerak, Arpornchayanon Olarn, Uttamo Nantawat, Leerapun Taninnit, Settakorn Jongkolnee

机构信息

Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Thailand; Excellence Center in Osteology Research and Training Center (ORTC), Chiang Mai University, Thailand.

Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Thailand.

出版信息

Cancer Epidemiol. 2015 Dec;39(6):956-63. doi: 10.1016/j.canep.2015.10.016. Epub 2015 Nov 9.

DOI:10.1016/j.canep.2015.10.016
PMID:26540607
Abstract

BACKGROUND

Osteosarcoma is a common and aggressive primary malignant bone tumor occurring in children and adolescents. It is one of the most aggressive human cancers and the most common cause of cancer-associated limb loss. As treatment in Thailand has produced a lower survival rate than in developed countries; therefore, this study identified survival rate and the poor prognostic factors of osteosarcoma in Northern Thailand.

METHODS

The retrospective cases of osteosarcoma, diagnosis between 1 January 1996 and 31 December 2013, were evaluated. Five and ten year overall survival rates were analyzed using time-to-event analysis. Potential prognostic factors were identified by multivariate regression analysis.

RESULTS

There were 208 newly diagnosed osteosarcomas during that period, and 144 cases met the criteria for analysis. The majority of the osteosarcoma cases (78.5%) were aged 0-24 years. The overall 5- and 10-year survival rates were 37.9% and 33.6%, respectively. Presence of metastasis at initial examination, delayed and against treatment co-operation, and axial skeletal location were identified as independent prognostic factors for survival, with hazard ratios of 4.3, 2.5 and 3.8, and 3.1, respectively.

CONCLUSIONS

This osteosarcoma cohort had a relatively poor overall survival rate. The prognostic factors identified would play a critical role in modifying survival rates of osteosarcoma patients; as rapid disease recognition, a better treatment counselling, as well as improving of chemotherapeutic regimens were found to be important in improving the overall survival rate in Thailand.

摘要

背景

骨肉瘤是一种常见且侵袭性强的原发性恶性骨肿瘤,发生于儿童和青少年。它是人类最具侵袭性的癌症之一,也是癌症相关肢体缺失的最常见原因。由于泰国的治疗生存率低于发达国家;因此,本研究确定了泰国北部骨肉瘤的生存率及不良预后因素。

方法

对1996年1月1日至2013年12月31日期间诊断的骨肉瘤回顾性病例进行评估。采用事件发生时间分析方法分析5年和10年总生存率。通过多因素回归分析确定潜在的预后因素。

结果

在此期间有208例新诊断的骨肉瘤,144例符合分析标准。大多数骨肉瘤病例(78.5%)年龄在0 - 24岁。5年和10年总生存率分别为37.9%和33.6%。初次检查时存在转移、延迟治疗及不配合治疗以及轴向骨骼部位被确定为生存的独立预后因素,风险比分别为4.3、2.5和3.8以及3.1。

结论

该骨肉瘤队列的总生存率相对较低。所确定的预后因素将在改善骨肉瘤患者生存率方面发挥关键作用;因为快速的疾病识别、更好的治疗咨询以及改进化疗方案对于提高泰国的总生存率很重要。

相似文献

1
Survival rate and prognostic factors of conventional osteosarcoma in Northern Thailand: A series from Chiang Mai University Hospital.泰国北部传统骨肉瘤的生存率及预后因素:清迈大学医院的系列研究
Cancer Epidemiol. 2015 Dec;39(6):956-63. doi: 10.1016/j.canep.2015.10.016. Epub 2015 Nov 9.
2
The extremity localized classic osteosarcomas have better survival than the axial non-classics.局限性经典型骨外骨肉瘤的存活率高于轴外非经典型。
World J Surg Oncol. 2018 Feb 23;16(1):39. doi: 10.1186/s12957-018-1344-3.
3
AgeStandardized Incidence Rates and Survival of Osteosarcoma in Northern Thailand.泰国北部骨肉瘤的年龄标准化发病率和生存率
Asian Pac J Cancer Prev. 2016;17(7):3455-8.
4
Epidemiologic study of 112 osteosarcomas in Chiang Mai University Hospital, Thailand.泰国清迈大学医院112例骨肉瘤的流行病学研究。
J Med Assoc Thai. 2007 Jul;90(7):1400-5.
5
Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark.在丹麦东部的一个单一机构进行了 21 年的研究,评估了高级肢端骨肉瘤诊断时的生存和预后因素。
Acta Oncol. 2018 Mar;57(3):420-425. doi: 10.1080/0284186X.2017.1351620. Epub 2017 Jul 25.
6
The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.根据年龄分组的骨肉瘤患者的结局和预后因素:一项日本全国性研究,重点关注年龄差异。
BMC Cancer. 2018 May 31;18(1):614. doi: 10.1186/s12885-018-4487-2.
7
Prognostic factors and survival rate of osteosarcoma: A single-institution study.骨肉瘤的预后因素及生存率:一项单机构研究。
Asia Pac J Clin Oncol. 2017 Apr;13(2):e104-e110. doi: 10.1111/ajco.12346. Epub 2015 Apr 13.
8
Proximal location in extremity long bones is a poor prognostic factor for osteosarcoma: A retrospective cohort study of 153 patients.肢体长骨近端位置是骨肉瘤的不良预后因素:一项对153例患者的回顾性队列研究。
Acta Oncol. 2016 Aug;55(8):1036-9. doi: 10.3109/0284186X.2016.1156740. Epub 2016 May 4.
9
Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.台湾某单一机构小儿肢体骨肉瘤的经验:预后因素及对生存的影响。
Ann Surg Oncol. 2015 Apr;22(4):1080-7. doi: 10.1245/s10434-014-4154-z. Epub 2014 Oct 17.
10
Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.AKT2的高表达与人类骨肉瘤的疾病严重程度和不良预后相关。
Mol Med Rep. 2014 Aug;10(2):737-42. doi: 10.3892/mmr.2014.2314. Epub 2014 Jun 10.

引用本文的文献

1
Development and validation of a predictive score for chemoresistance in high-grade osteosarcoma at baseline.高级别骨肉瘤基线化疗耐药预测评分的开发与验证
Front Med (Lausanne). 2025 Jul 4;12:1588302. doi: 10.3389/fmed.2025.1588302. eCollection 2025.
2
Long non-coding RNA AC133552.2: biomarker and therapeutic target in osteosarcoma via PANoptosis gene screening.长链非编码RNA AC133552.2:通过PANoptosis基因筛选成为骨肉瘤的生物标志物和治疗靶点
Sci Rep. 2025 Mar 17;15(1):9180. doi: 10.1038/s41598-025-93167-2.
3
Identification and functional characterization of T-cell exhaustion-associated lncRNA AL031775.1 in osteosarcoma: a novel therapeutic target.
骨肉瘤中T细胞耗竭相关长链非编码RNA AL031775.1的鉴定及功能表征:一个新的治疗靶点
Front Immunol. 2025 Feb 24;16:1517971. doi: 10.3389/fimmu.2025.1517971. eCollection 2025.
4
Characteristics and prognostic factors of adult patients with osteosarcoma from the SEER database.SEER 数据库中骨肿瘤患者的特征和预后因素。
Medicine (Baltimore). 2023 Sep 15;102(37):e33653. doi: 10.1097/MD.0000000000033653.
5
CircRASSF2 promotes IGF1R and osteosarcoma metastasis via sponging miR-6838-5p.环状RASSF2通过吸附miR-6838-5p促进IGF1R和骨肉瘤转移。
Ann Transl Med. 2022 Jan;10(1):11. doi: 10.21037/atm-21-6123.
6
IMPDH2 and HPRT expression and a prognostic significance in preoperative and postoperative patients with osteosarcoma.骨肉瘤术前术后患者中 IMPDH2 和 HPRT 的表达及其预后意义。
Sci Rep. 2021 May 25;11(1):10887. doi: 10.1038/s41598-021-90456-4.
7
Factors Affecting Prognosis and Survival in Extremity Osteosarcoma.影响肢体骨肉瘤预后和生存的因素
Indian J Surg Oncol. 2021 Mar;12(1):199-206. doi: 10.1007/s13193-020-01277-2. Epub 2021 Jan 6.
8
PTHR1 in osteosarcoma: Specific molecular mechanisms and comprehensive functional perspective.骨肉瘤中 PTHR1:特定的分子机制和全面的功能视角。
J Cell Mol Med. 2021 Apr;25(7):3175-3181. doi: 10.1111/jcmm.16420. Epub 2021 Mar 6.
9
Prognostic factors in osteosarcoma: A study level meta-analysis and systematic review of current practice.骨肉瘤的预后因素:一项研究水平的Meta分析及当前实践的系统评价
J Bone Oncol. 2020 Feb 21;21:100281. doi: 10.1016/j.jbo.2020.100281. eCollection 2020 Apr.
10
Zinc promotes cell apoptosis via activating the Wnt-3a/β-catenin signaling pathway in osteosarcoma.锌通过激活骨肉瘤中的 Wnt-3a/β-连环蛋白信号通路促进细胞凋亡。
J Orthop Surg Res. 2020 Feb 19;15(1):57. doi: 10.1186/s13018-020-01585-x.